Search clinical trials for: allotx

Total 2 results

M.D. Anderson Cancer Center
National Cancer Institute (NCI); Celgene Corporation

Completed

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Leukemia | Stem Cell Transplantation

United States
M.D. Anderson Cancer Center
Celgene

Completed

Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)

Leukemia | AML | MDS

United States

3

Subscribe